These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 6172758)

  • 1. Characterization of catecholamine binding sites in the rat brain.
    Agrawal AK; Bondy SC
    Neurotoxicology; 1981 Oct; 2(2):365-71. PubMed ID: 6172758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electroconvulsive shock and neurotransmitter receptors: implications for mechanism of action and adverse effects of electroconvulsive therapy.
    Lerer B
    Biol Psychiatry; 1984 Mar; 19(3):361-83. PubMed ID: 6144329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of dopamine receptor sites labeled by [3H]-S-sulpiride and [3H]-spiperone in striatum.
    Zahniser NR; Dubocovich ML
    J Pharmacol Exp Ther; 1983 Dec; 227(3):592-9. PubMed ID: 6655559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High doses of morphine do not change characteristics of the cerebral catecholamine receptors in the rat.
    Rokosz-Kozłowska A; Antkiewicz-Michaluk L; Vetulani J
    Pol J Pharmacol Pharm; 1988; 40(4):387-92. PubMed ID: 2851780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do catecholestrogens interact with the in vitro binding of radioligands to catecholamine receptors?
    Hiemke C; Banger M; Ghraf R; Knuppen R
    J Steroid Biochem; 1983 Oct; 19(4):1469-74. PubMed ID: 6316030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological properties of (3H) dihydroergokryptine binding sites associated with alpha noradrenergic receptors in rat brain membranes.
    Greenberg DA; Snyder SH
    Mol Pharmacol; 1978 Jan; 14(1):38-49. PubMed ID: 203845
    [No Abstract]   [Full Text] [Related]  

  • 7. Factors contributing to the up regulation of dopaminergic receptors by chronic haloperidol.
    Schweitzer JW; Schwartz R; Friedhoff AJ
    Res Commun Chem Pathol Pharmacol; 1982 Oct; 38(1):21-30. PubMed ID: 7146618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of catecholamine-derived alkaloids with central neurotransmitter receptors.
    Nimit Y; Schulze I; Cashaw JL; Ruchirawat S; Davis VE
    J Neurosci Res; 1983; 10(2):175-89. PubMed ID: 6313954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Competition by estrogens for catecholamine receptor binding in vitro.
    Paden CM; McEwen BS; Fishman J; Snyder L; DeGroff V
    J Neurochem; 1982 Aug; 39(2):512-20. PubMed ID: 7086432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of the effect of substituted benzamides in radioreceptor binding assays with their effects on brain dopaminergic systems in vivo.
    Lin CW; Wilk S
    Adv Biochem Psychopharmacol; 1982; 35():51-60. PubMed ID: 6183929
    [No Abstract]   [Full Text] [Related]  

  • 11. Age-related changes in rat brain dopaminergic receptors.
    Petkov VV; Petkov VD; Grahovska T; Konstantinova E
    Acta Physiol Pharmacol Bulg; 1984; 10(4):16-27. PubMed ID: 6535368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential competition by L-alpha-methyldopa metabolites for adrenergic receptors in rat forebrain.
    Goldberg MR; Tung CS; Feldman RD; Smith HE; Oates JA; Robertson D
    J Pharmacol Exp Ther; 1982 Mar; 220(3):552-60. PubMed ID: 7062266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lasting changes in high affinity 3H-spiperone binding to the rat striatum and mesolimbic area after chronic methamphetamine administration: evaluation of dopaminergic and serotonergic receptor components.
    Akiyama K; Sato M; Kashihara K; Otsuki S
    Biol Psychiatry; 1982 Dec; 17(12):1389-402. PubMed ID: 7159638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of long-term treatment of haloperidol on D2 dopamine receptors in various areas of rat brain.
    Watanabe M; Ohtakeno S; Watanabe H; Mamiya G; Ichinowatari N
    Yakubutsu Seishin Kodo; 1993 Oct; 13(5):315-9. PubMed ID: 8266741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in serotonin, but not catecholamine, receptor binding in the brain of morphine-dependent rats.
    Mennini T; Poggesi E; Cotecchia S; De Blasi A; Samanin R
    Mol Pharmacol; 1981 Sep; 20(2):237-9. PubMed ID: 7197752
    [No Abstract]   [Full Text] [Related]  

  • 16. Characterization of solubilized serotonin (S2) receptors in rat brain.
    Ilien B; Gorissen H; Laduron PM
    Mol Pharmacol; 1982 Sep; 22(2):243-9. PubMed ID: 7144728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antagonism by supidimide of haloperidol-induced augmentation of [3H]-spiperone binding in rat striatum.
    Hennies HH; Hess V; Flohé L
    Arzneimittelforschung; 1984; 34(11):1481-4. PubMed ID: 6543122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of adrenergic receptor binding in rat lung: physiological regulation.
    Latifpour J; Bylund DB
    J Pharmacol Exp Ther; 1983 Jan; 224(1):186-92. PubMed ID: 6294276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct binding of 3H-lisuride to adrenergic and serotonergic receptors.
    Battaglia G; Titeler M
    Life Sci; 1981 Aug; 29(9):909-16. PubMed ID: 7300582
    [No Abstract]   [Full Text] [Related]  

  • 20. [Phenylethylamine fluorides. II. Synthesis and neurobiochemistry in the rat].
    Charlon C; Luu-Duc C; Huguet F; Gérard P; Narcisse G
    Farmaco Sci; 1986 Aug; 41(8):586-96. PubMed ID: 3743750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.